Evidence network for deaths_(OS)
T vs. C | docetaxel | atezolizumab alone | nivolumab alone | avelumab alone | Tislelizumab |
docetaxel | --- | 1.27 1.12; 1.44 | 1.47 1.12; 1.93 | 1.11 0.93; 1.33 | NA |
atezolizumab alone | 0.79 0.70; 0.89 | --- | 1.16 0.86; 1.57 | 0.88 0.70; 1.09 | NA |
nivolumab alone | 0.68 0.52; 0.89 | 0.86 0.64; 1.17 | --- | 0.76 0.54; 1.05 | NA |
avelumab alone | 0.90 0.75; 1.08 | 1.14 0.92; 1.42 | 1.32 0.95; 1.84 | --- | NA |
Tislelizumab | NA | NA | NA | NA | --- |
pathologies: 37
- treatments: 940
result logic